本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Heron Therapeutics Inc.

0.3155
-0.0068-2.11%
盤後0.32180.0063+2.00%19:30 EDT
成交量:137.17萬
成交額:44.00萬
市值:5,962.95萬
市盈率:-1.71
高:0.3312
開:0.3300
低:0.3114
收:0.3223
52周最高:1.58
52周最低:0.2975
股本:1.89億
流通股本:1.47億
量比:0.96
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-0.1842
每股收益(LYR):-0.1211
淨資產收益率:-2408.88%
總資產收益率:-2.80%
市淨率:10.18
市盈率(LYR):-2.60

資料載入中...

2023/03/06

重要事件披露

8-K - Current report
2023/02/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/22

重要事件披露

8-K - Current report
2023/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/01/31

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/12/29

重要事件披露

8-K - Current report
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/19

重要事件披露

8-K - Current report
2022/09/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report